MCLA-158, a bAb that specifically triggers epidermal growth factor receptor degradation in LGR5+ cancer stem cells but shows minimal toxicity toward healthy LGR5+ colon stem cells, was tested in a large-scale functional screen. The gene discussed is LGR5; the disease is cancer.